Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer

Completed · Phase 4 · Has a placebo group

Conditions studied: Sleep Initiation and Maintenance Disorders

In brief

To assess the effectiveness of Lunesta on cancer patients who have received chemotherapy and who require patient controlled analgesia (PCA), specifically to assess whether Lunesta will: * improve sleep thereby decreasing need for opiates via PCA * improve sleep thereby decreasing pain by self report * improve sleep thereby decreasing fatigue by self report

Key facts

Study ID

NCT00365261

Run by

University of California, San Diego

People needed

45

Starts

2006-09-01

Expected to finish

2009-12-01

Last updated by the study team

2016-07-11

Who can join

Age: 20 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients hospitalized for chemotherapy or blood/bone marrow transplant.
• Age 20 - 75
• Not currently regularly taking any prescribed sleeping pill more often than 4x/week.
• Can tolerate oral medication.

You may not qualify if…

• Patients with a current history of substance abuse
• Patients with a history of allergic response to Lunesta.
• Patient who require additional oral or parenteral opioids after starting PCA opioid treatment.

Where it is running

• UCSD Thornton Hospital — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.